Loading…

Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy

The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were...

Full description

Saved in:
Bibliographic Details
Published in:Journal of kidney cancer and VHL 2022-10, Vol.9 (4), p.1-5
Main Authors: Sharafeldeen, Mohamed, Sameh, Wael, Mehrnoush, Vahid, Alaref, Amer, Rozenberg, Radu, Ismail, Asmaa, Elmansy, Hazem, Shahrour, Walid, Zakaria, Ahmed, Elmeslemany, Osama, Burute, Nishigandha, Shuster, Anatoly, Prowse, Owen, Kotb, Ahmed
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 5
container_issue 4
container_start_page 1
container_title Journal of kidney cancer and VHL
container_volume 9
creator Sharafeldeen, Mohamed
Sameh, Wael
Mehrnoush, Vahid
Alaref, Amer
Rozenberg, Radu
Ismail, Asmaa
Elmansy, Hazem
Shahrour, Walid
Zakaria, Ahmed
Elmeslemany, Osama
Burute, Nishigandha
Shuster, Anatoly
Prowse, Owen
Kotb, Ahmed
description The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were collected. Surgical data including surgical and ischemic times as well as intra and postoperative complications were collected. Pre- and postoperative estimated glomerular filtration rate (eGFR) data were collected and correlated as well as postoperative complications and recurrence. We could identify 47 patients managed by PN for radiologically confirmed >4 cm renal masses. The mean age of the patients was 55.7 ± 13.4, including 29 males and 18 females. Masses were T1b and T2 in 40 and 7 patients, respectively. The mean tumor size was 6.2 ± 1.5 cm. Using renal nephrometry score; 8, 28, and 11 had low, moderate, and high complexity, respectively. Renal cell carcinoma (RCC) was identified in 42 patients. Five patients out of 42 cancerous cases (12%) had pathological T3 RCC. The mean preoperative and postoperative eGFR were 89.09 ± 12.41 and 88.50 ± 10.50, respectively (P 0.2). The median follow-up was 14 months and within that short time, no patient had evidence for cancer recurrence. PN for large renal masses is safe in experienced hands and should be attempted in a higher percentage of patients, regardless of the tumor complexity. No cancer recurrence or deterioration of renal function was observed within our short-term follow-up.
doi_str_mv 10.15586/jkcvhl.v9i4.255
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9550639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2730648226</sourcerecordid><originalsourceid>FETCH-LOGICAL-c214t-852281e73ac9462897b2081fa5e96bce586ef33c147dc81f4ca05ced7d3538703</originalsourceid><addsrcrecordid>eNpVkEtPwzAQhC0EElXpnWOOcEi7tmPHuSChipdUHkLlbDnOhqYkcbGTSv33BFohOO1qZzQ7-gg5pzClQig5W3_Y7aqebrMqmTIhjsiIMeCxUEwe_9lPySSENQBQkUlQMCKXL8Z3lamjJ9ysPNrONbuodD5a0ny2ZNErtoP4aEI4IyelqQNODnNM3m5vlvP7ePF89zC_XsSW0aSLlWBMUUy5sVkimcrSnIGipRGYydzi0BZLzi1N0sIO98QaEBaLtOCCqxT4mFztczd93mBhse28qfXGV43xO-1Mpf8rbbXS726rMyFA8mwIuDgEePfZY-h0UwWLdW1adH3QLOUgE8WYHKywt1rvQvBY_r6hoH_I6j1Z_U1WD2T5FybobTQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2730648226</pqid></control><display><type>article</type><title>Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Sharafeldeen, Mohamed ; Sameh, Wael ; Mehrnoush, Vahid ; Alaref, Amer ; Rozenberg, Radu ; Ismail, Asmaa ; Elmansy, Hazem ; Shahrour, Walid ; Zakaria, Ahmed ; Elmeslemany, Osama ; Burute, Nishigandha ; Shuster, Anatoly ; Prowse, Owen ; Kotb, Ahmed</creator><creatorcontrib>Sharafeldeen, Mohamed ; Sameh, Wael ; Mehrnoush, Vahid ; Alaref, Amer ; Rozenberg, Radu ; Ismail, Asmaa ; Elmansy, Hazem ; Shahrour, Walid ; Zakaria, Ahmed ; Elmeslemany, Osama ; Burute, Nishigandha ; Shuster, Anatoly ; Prowse, Owen ; Kotb, Ahmed</creatorcontrib><description>The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were collected. Surgical data including surgical and ischemic times as well as intra and postoperative complications were collected. Pre- and postoperative estimated glomerular filtration rate (eGFR) data were collected and correlated as well as postoperative complications and recurrence. We could identify 47 patients managed by PN for radiologically confirmed &gt;4 cm renal masses. The mean age of the patients was 55.7 ± 13.4, including 29 males and 18 females. Masses were T1b and T2 in 40 and 7 patients, respectively. The mean tumor size was 6.2 ± 1.5 cm. Using renal nephrometry score; 8, 28, and 11 had low, moderate, and high complexity, respectively. Renal cell carcinoma (RCC) was identified in 42 patients. Five patients out of 42 cancerous cases (12%) had pathological T3 RCC. The mean preoperative and postoperative eGFR were 89.09 ± 12.41 and 88.50 ± 10.50, respectively (P 0.2). The median follow-up was 14 months and within that short time, no patient had evidence for cancer recurrence. PN for large renal masses is safe in experienced hands and should be attempted in a higher percentage of patients, regardless of the tumor complexity. No cancer recurrence or deterioration of renal function was observed within our short-term follow-up.</description><identifier>ISSN: 2203-5826</identifier><identifier>EISSN: 2203-5826</identifier><identifier>DOI: 10.15586/jkcvhl.v9i4.255</identifier><language>eng</language><publisher>Codon Publications</publisher><subject>Kidney Cancer: Original</subject><ispartof>Journal of kidney cancer and VHL, 2022-10, Vol.9 (4), p.1-5</ispartof><rights>Sharafeldeen M, et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550639/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550639/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids></links><search><creatorcontrib>Sharafeldeen, Mohamed</creatorcontrib><creatorcontrib>Sameh, Wael</creatorcontrib><creatorcontrib>Mehrnoush, Vahid</creatorcontrib><creatorcontrib>Alaref, Amer</creatorcontrib><creatorcontrib>Rozenberg, Radu</creatorcontrib><creatorcontrib>Ismail, Asmaa</creatorcontrib><creatorcontrib>Elmansy, Hazem</creatorcontrib><creatorcontrib>Shahrour, Walid</creatorcontrib><creatorcontrib>Zakaria, Ahmed</creatorcontrib><creatorcontrib>Elmeslemany, Osama</creatorcontrib><creatorcontrib>Burute, Nishigandha</creatorcontrib><creatorcontrib>Shuster, Anatoly</creatorcontrib><creatorcontrib>Prowse, Owen</creatorcontrib><creatorcontrib>Kotb, Ahmed</creatorcontrib><title>Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy</title><title>Journal of kidney cancer and VHL</title><description>The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were collected. Surgical data including surgical and ischemic times as well as intra and postoperative complications were collected. Pre- and postoperative estimated glomerular filtration rate (eGFR) data were collected and correlated as well as postoperative complications and recurrence. We could identify 47 patients managed by PN for radiologically confirmed &gt;4 cm renal masses. The mean age of the patients was 55.7 ± 13.4, including 29 males and 18 females. Masses were T1b and T2 in 40 and 7 patients, respectively. The mean tumor size was 6.2 ± 1.5 cm. Using renal nephrometry score; 8, 28, and 11 had low, moderate, and high complexity, respectively. Renal cell carcinoma (RCC) was identified in 42 patients. Five patients out of 42 cancerous cases (12%) had pathological T3 RCC. The mean preoperative and postoperative eGFR were 89.09 ± 12.41 and 88.50 ± 10.50, respectively (P 0.2). The median follow-up was 14 months and within that short time, no patient had evidence for cancer recurrence. PN for large renal masses is safe in experienced hands and should be attempted in a higher percentage of patients, regardless of the tumor complexity. No cancer recurrence or deterioration of renal function was observed within our short-term follow-up.</description><subject>Kidney Cancer: Original</subject><issn>2203-5826</issn><issn>2203-5826</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkEtPwzAQhC0EElXpnWOOcEi7tmPHuSChipdUHkLlbDnOhqYkcbGTSv33BFohOO1qZzQ7-gg5pzClQig5W3_Y7aqebrMqmTIhjsiIMeCxUEwe_9lPySSENQBQkUlQMCKXL8Z3lamjJ9ysPNrONbuodD5a0ny2ZNErtoP4aEI4IyelqQNODnNM3m5vlvP7ePF89zC_XsSW0aSLlWBMUUy5sVkimcrSnIGipRGYydzi0BZLzi1N0sIO98QaEBaLtOCCqxT4mFztczd93mBhse28qfXGV43xO-1Mpf8rbbXS726rMyFA8mwIuDgEePfZY-h0UwWLdW1adH3QLOUgE8WYHKywt1rvQvBY_r6hoH_I6j1Z_U1WD2T5FybobTQ</recordid><startdate>20221006</startdate><enddate>20221006</enddate><creator>Sharafeldeen, Mohamed</creator><creator>Sameh, Wael</creator><creator>Mehrnoush, Vahid</creator><creator>Alaref, Amer</creator><creator>Rozenberg, Radu</creator><creator>Ismail, Asmaa</creator><creator>Elmansy, Hazem</creator><creator>Shahrour, Walid</creator><creator>Zakaria, Ahmed</creator><creator>Elmeslemany, Osama</creator><creator>Burute, Nishigandha</creator><creator>Shuster, Anatoly</creator><creator>Prowse, Owen</creator><creator>Kotb, Ahmed</creator><general>Codon Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20221006</creationdate><title>Partial Nephrectomy for T1b/T2 Renal Mass</title><author>Sharafeldeen, Mohamed ; Sameh, Wael ; Mehrnoush, Vahid ; Alaref, Amer ; Rozenberg, Radu ; Ismail, Asmaa ; Elmansy, Hazem ; Shahrour, Walid ; Zakaria, Ahmed ; Elmeslemany, Osama ; Burute, Nishigandha ; Shuster, Anatoly ; Prowse, Owen ; Kotb, Ahmed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c214t-852281e73ac9462897b2081fa5e96bce586ef33c147dc81f4ca05ced7d3538703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Kidney Cancer: Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharafeldeen, Mohamed</creatorcontrib><creatorcontrib>Sameh, Wael</creatorcontrib><creatorcontrib>Mehrnoush, Vahid</creatorcontrib><creatorcontrib>Alaref, Amer</creatorcontrib><creatorcontrib>Rozenberg, Radu</creatorcontrib><creatorcontrib>Ismail, Asmaa</creatorcontrib><creatorcontrib>Elmansy, Hazem</creatorcontrib><creatorcontrib>Shahrour, Walid</creatorcontrib><creatorcontrib>Zakaria, Ahmed</creatorcontrib><creatorcontrib>Elmeslemany, Osama</creatorcontrib><creatorcontrib>Burute, Nishigandha</creatorcontrib><creatorcontrib>Shuster, Anatoly</creatorcontrib><creatorcontrib>Prowse, Owen</creatorcontrib><creatorcontrib>Kotb, Ahmed</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of kidney cancer and VHL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharafeldeen, Mohamed</au><au>Sameh, Wael</au><au>Mehrnoush, Vahid</au><au>Alaref, Amer</au><au>Rozenberg, Radu</au><au>Ismail, Asmaa</au><au>Elmansy, Hazem</au><au>Shahrour, Walid</au><au>Zakaria, Ahmed</au><au>Elmeslemany, Osama</au><au>Burute, Nishigandha</au><au>Shuster, Anatoly</au><au>Prowse, Owen</au><au>Kotb, Ahmed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy</atitle><jtitle>Journal of kidney cancer and VHL</jtitle><date>2022-10-06</date><risdate>2022</risdate><volume>9</volume><issue>4</issue><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>2203-5826</issn><eissn>2203-5826</eissn><abstract>The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were collected. Surgical data including surgical and ischemic times as well as intra and postoperative complications were collected. Pre- and postoperative estimated glomerular filtration rate (eGFR) data were collected and correlated as well as postoperative complications and recurrence. We could identify 47 patients managed by PN for radiologically confirmed &gt;4 cm renal masses. The mean age of the patients was 55.7 ± 13.4, including 29 males and 18 females. Masses were T1b and T2 in 40 and 7 patients, respectively. The mean tumor size was 6.2 ± 1.5 cm. Using renal nephrometry score; 8, 28, and 11 had low, moderate, and high complexity, respectively. Renal cell carcinoma (RCC) was identified in 42 patients. Five patients out of 42 cancerous cases (12%) had pathological T3 RCC. The mean preoperative and postoperative eGFR were 89.09 ± 12.41 and 88.50 ± 10.50, respectively (P 0.2). The median follow-up was 14 months and within that short time, no patient had evidence for cancer recurrence. PN for large renal masses is safe in experienced hands and should be attempted in a higher percentage of patients, regardless of the tumor complexity. No cancer recurrence or deterioration of renal function was observed within our short-term follow-up.</abstract><pub>Codon Publications</pub><doi>10.15586/jkcvhl.v9i4.255</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2203-5826
ispartof Journal of kidney cancer and VHL, 2022-10, Vol.9 (4), p.1-5
issn 2203-5826
2203-5826
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9550639
source PubMed Central Free; Publicly Available Content Database
subjects Kidney Cancer: Original
title Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A58%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Partial%20Nephrectomy%20for%20T1b/T2%20Renal%20Mass:%20An%20Added%20Shift%20from%20Radical%20Nephrectomy&rft.jtitle=Journal%20of%20kidney%20cancer%20and%20VHL&rft.au=Sharafeldeen,%20Mohamed&rft.date=2022-10-06&rft.volume=9&rft.issue=4&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=2203-5826&rft.eissn=2203-5826&rft_id=info:doi/10.15586/jkcvhl.v9i4.255&rft_dat=%3Cproquest_pubme%3E2730648226%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c214t-852281e73ac9462897b2081fa5e96bce586ef33c147dc81f4ca05ced7d3538703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2730648226&rft_id=info:pmid/&rfr_iscdi=true